Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

635

HTML

4306

Figures (1-1)

243

Tables (1-6)

269

Sum=5453

Jan 21, 2008 (publication date) through Jan 28, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jan 21, 2008; 14(3): 331-337
Published online Jan 21, 2008. doi: 10.3748/wjg.14.331

Table 3 Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis (PSC)

Institution (country of origin)	Number of patients with PSC	Percentage with IBD
Royal Free Hospital (UK)[17]	29	72
Mayo Clinic (USA)[18]	50	70
Huddinge (Sweden)	305	72
King’s College London (UK-children)	13	77
Okolicsanyi (Italy)[19]	82	54
Escorsell (Spain)	43	47
Okada (Japan)[20]	155	23

Citation: Saich R, Chapman R. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol 2008; 14(3): 331-337
URL: https://www.wjgnet.com/1007-9327/full/v14/i3/331.htm
DOI: https://dx.doi.org/10.3748/wjg.14.331